Sort
11,323 grants matching “glioblastoma”
Targeting Glioblastoma Using Novel Small Molecule HIF-1 Pathway Inhibitors
$427,765Erwin G Van Meir · Emory University · R01 · FY2011 · CA
Chimeric anti-fibulin-3 reagents for targeted therapy of glioblastoma
$427,760Mariano Sebastian Viapiano · Upstate Medical University · R21 · FY2016 · NS
2D MR Correlational Spectroscopy Platform for Molecular and Genetic Characterizations of Glioma
$427,689Hui Mao · Emory University · R01 · FY2017 · CA
Targeting Glioblastoma Stem Cells through Epigenetic Reprogramming
$427,647Xing Fan · University Of Michigan At Ann Arbor · R01 · FY2021 · NS
Targeting IDH mutations to improve seizure control in glioma patients
$427,577Craig Michael Horbinski · Northwestern University At Chicago · R01 · FY2021 · NS
Gene targets of OLIG2 in malignant glioma stem cells
$427,500Charles Stiles · Dana-Farber Cancer Inst · R01 · FY2009 · NS
Gene targets of OLIG2 in malignant glioma stem cells
$427,500Charles Stiles · Dana-Farber Cancer Inst · R01 · FY2007 · NS
Gene targets of OLIG2 in malignant glioma stem cells
$427,500Charles Stiles · Dana-Farber Cancer Inst · R01 · FY2008 · NS
Harnessing Continuous Liquid Interface 3D Printing to Improve Tumor-homing Stem Cell Therapy for Post-surgical Brain Cancer
$427,463Shawn Hingtgen · Univ Of North Carolina Chapel Hill · R01 · FY2023 · CA
Novel Roles of TAZ and YAP in DNA Damage Repair with 3D Genome Organization and the Therapeutic Resistance in Glioblastoma
$427,263Krishna Pl Bhat · Mayo Clinic Arizona · R01 · FY2024 · NS
The Role of Collagen and its Signaling Mechanisms in Glioma Progression and Invasion.
$427,257Pedro R Lowenstein · University Of Michigan At Ann Arbor · R01 · FY2025 · NS
Establishment of immunocompetent spontaneous glioma model to study glioma-associated astrocytes
$426,938Tomasz K Kordula · Virginia Commonwealth University · R21 · FY2021 · NS
Metabolism Informs Intertumoral & Intratumoral Heterogeneity
$426,906Jeremy N Rich · Cleveland Clinic Lerner Com-Cwru · R01 · FY2014 · NS
A Bioprinted Volumetric Model of Vascularized Glioblastoma
$426,834Y. Shrike Zhang · Brigham And Women'S Hospital · R01 · FY2025 · CA
Identification of Genetic Alterations Responsible for Primary GBM Clonal Evoluti
$426,766Alnawaz Rehemtulla · University Of Michigan At Ann Arbor · P01 · FY2014 · CA
Mechanisms and Function of Autophagy in Cancer
$426,550Xuejun Jiang · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
Mechanisms and Function of Autophagy in Cancer
$426,550Xuejun Jiang · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
Mechanisms and Function of Autophagy in Cancer
$426,550Xuejun Jiang · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
Ultrasensitive Approaches for Complex Animal Proteomics
$426,488Satya Prakash Saxena · Calibrant Biosystems, Inc. · R44 · FY2009 · RR
Quantitative (Perfusion and Diffusion) MRI Biomarkers to Measure Glioma Response
$426,449Kathleen Marie Schmainda · Medical College Of Wisconsin · U01 · FY2016 · CA
Ultrasensitive Approaches for Complex Animal Proteomics
$426,277Xueping Fang · Calibrant Biosystems, Inc. · R44 · FY2010 · RR
Targeting of Mitochondrial Lon Protease as a Novel Therapy for Glioblastoma
$425,938Daniela Annenelie Bota · University Of California-Irvine · R01 · FY2020 · NS
Spherical Nucleic Acid nano-architectures as first-in-class cGAS agonists for the immunotherapeutic treatment of Glioblastoma.
$425,597Alexander H. Stegh · Washington University · R01 · FY2023 · CA
S100A4 mediated immune suppression in GBM
$425,493Kyuson Yun · Methodist Hospital Research Institute · R01 · FY2024 · NS
Characterizing inhibitors of tyrosine protein kinase ABL1 (ABL1) in human glioblastoma
$425,400Juan Marugan · National Center For Advancing Translational Sciences · ZIA · FY2022 · TR